{"address1": "3115 Merryfield Row", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 684 1300", "website": "https://www.gossamerbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 144, "companyOfficers": [{"maxAge": 1, "name": "Mr. Faheem  Hasnain", "age": 66, "title": "Co-Founder, CEO, President & Chairman", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 910263, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bryan  Giraudo", "age": 49, "title": "COO & CFO", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 708091, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert P. Smith", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 135795, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian  Waage J.D.", "age": 57, "title": "Executive Vice President of Technical Operations & Administration", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 583156, "exercisedValue": 0, "unexercisedValue": 20005}, {"maxAge": 1, "name": "Mr. Jeff  Boerneke", "title": "General Counsel & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jeanine  Anthony", "title": "Senior Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deanna  Weber", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard  Aranda M.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 625241, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn L. Peterson", "age": 65, "title": "Executive Vice President of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Cravets", "title": "Senior Vice President of Biometrics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.1, "open": 1.1, "dayLow": 0.9756, "dayHigh": 1.15, "regularMarketPreviousClose": 1.1, "regularMarketOpen": 1.1, "regularMarketDayLow": 0.9756, "regularMarketDayHigh": 1.15, "payoutRatio": 0.0, "beta": 1.863, "forwardPE": -1.4410145, "volume": 2368930, "regularMarketVolume": 2368930, "averageVolume": 1480971, "averageVolume10days": 1425740, "averageDailyVolume10Day": 1425740, "bid": 0.792, "ask": 1.25, "bidSize": 1, "askSize": 1, "marketCap": 225925840, "fiftyTwoWeekLow": 0.499, "fiftyTwoWeekHigh": 1.55, "priceToSalesTrailing12Months": 1.9696938, "fiftyDayAverage": 1.18972, "twoHundredDayAverage": 0.97357, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 134290096, "profitMargins": -0.49283, "floatShares": 183672034, "sharesOutstanding": 227220992, "sharesShort": 5741046, "sharesShortPriorMonth": 5717172, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0253, "heldPercentInsiders": 0.03284, "heldPercentInstitutions": 0.76514, "shortRatio": 3.32, "shortPercentOfFloat": 0.025999999, "impliedSharesOutstanding": 227220992, "bookValue": 0.13, "priceToBook": 7.648462, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -56528000, "trailingEps": -0.25, "forwardEps": -0.69, "enterpriseToRevenue": 1.171, "enterpriseToEbitda": -2.273, "52WeekChange": -0.104504526, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.9943, "targetHighPrice": 15.0, "targetLowPrice": 1.25, "targetMeanPrice": 7.60714, "targetMedianPrice": 8.0, "recommendationMean": 1.77778, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 294518016, "totalCashPerShare": 1.296, "ebitda": -59086000, "totalDebt": 202882000, "quickRatio": 6.662, "currentRatio": 6.885, "totalRevenue": 114701000, "debtToEquity": 687.922, "revenuePerShare": 0.507, "returnOnAssets": -0.11942001, "returnOnEquity": -1.22539, "grossProfits": 114701000, "freeCashflow": -16701500, "operatingCashflow": -3468000, "grossMargins": 1.0, "ebitdaMargins": -0.51513, "operatingMargins": -3.8520098, "financialCurrency": "USD", "symbol": "GOSS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -0.25, "epsForward": -0.69, "epsCurrentYear": -0.73333, "priceEpsCurrentYear": -1.3558698, "fiftyDayAverageChange": -0.19542003, "fiftyDayAverageChangePercent": -0.16425715, "twoHundredDayAverageChange": 0.020730019, "twoHundredDayAverageChangePercent": 0.021292787, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": -9.609092, "regularMarketPrice": 0.9943, "shortName": "Gossamer Bio, Inc.", "longName": "Gossamer Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1549636200000, "preMarketChange": 0.0055999756, "preMarketChangePercent": 0.56320786, "preMarketPrice": 0.9999, "regularMarketChange": -0.105700016, "regularMarketDayRange": "0.9756 - 1.15", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1480971, "fiftyTwoWeekLowChange": 0.4953, "fiftyTwoWeekLowChangePercent": 0.9925851, "fiftyTwoWeekRange": "0.499 - 1.55", "fiftyTwoWeekHighChange": -0.55569994, "fiftyTwoWeekHighChangePercent": -0.3585161, "fiftyTwoWeekChangePercent": -10.450453, "earningsTimestamp": 1741896060, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743595204, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_548541911", "displayName": "Gossamer Bio", "trailingPegRatio": null}